Top secret US research lab studying SARS-CoV-2 shut amid safety concerns
The Integrated Research Facility (IRL) – which is located at a US Army base in Fort Detrick, Maryland – was told by email to stop all experimental work by 5pm on April 29 and its director was placed on administrative leave.
The high security facility, which was once the centre of the US biological weapons program, is believed by many in China to have sparked the Covid-19 pandemic.
Until Tuesday, when its doors were locked, the lab conducted research for the prevention and treatment of 'high consequence' diseases including Ebola, Sars-Cov-2 Lassa fever, Marburg and Eastern equine encephalitis.
Bradley Moss, the communications director for the US National institutes for Health (NIH), told WIRED magazine that the lab had been closed amid safety concerns.
'NIH has implemented a research pause – referred to as a safety stand-down – at the Integrated Research Facility at Fort Detrick. This decision follows identification and documentation of personnel issues involving contract staff that compromised the facility's safety culture, prompting this research pause,' he said.
'During the stand-down, no research will be conducted, and access will be limited to essential personnel only, to safeguard the facility and its resources.'
An email seen by WIRED, further revealed that the facility's director had been placed on administrative leave, while the freezers in the facility's biosafety-level-4 (BSL4) labs padlocked shut.
There are only around a dozen BSL4 labs in North America studying the world's most dangerous diseases, but the IRF facility is also one of just a handful globally that is able to perform medical imaging on animals infected with high consequence diseases.
It has 168 employees and is part of the National Institute of Allergy and Infectious Diseases – which Dr Anthony Fauci led for 38 years.
In August 2019, its germ research operations were temporarily shut down following serious safety violations – an unfortunate fact that has enabled the Chinese authorities to magnify un-evidenced conspiracy theories about the lab's role in the Covid-19 pandemic.
While the consensus among scientists globally is that Covid-19 most probably had natural origins, a leak from a high security lab remains a possibility.
The National Institute of Allergy and Infectious Diseases and its labs have been under scrutiny since Robert F Kennedy, President Donald Trump's controversial pick to lead the Department of Health and Human Services, assumed office.
The department has since announced that 10,000 people would lose their jobs – including those at the NIH, the Food and Drug Administration, and the Centres for Disease Control and Prevention – as Mr Trump and Elon Musk's attempt to reduce government spending.
But there are concerns that overnight funding cuts could be a major setback for research.
'The sustained attacks on collaborative US biomedical science and public health are already destroying disease surveillance systems and game-changing clinical trials that will result in avoidable deaths and morbidities for years to come in some of the poorest countries,' said Prof Stuart Neil, head of the department of infectious diseases at King's College London.
'These aren't on-off switches that you restore with a flick of a finger if someone on high changes their minds. This is wilful vandalism of research and treatment programmes that have taken years to establish – things that you could legitimately say made America great,' he told the Telegraph.
This week, Nature also reported that an upcoming NIH policy will at least temporarily stop funding to laboratories and hospitals outside the US. While the final text has not yet been agreed, it could have major ramifications on international partnerships.
In 2023, about 15 per cent of NIH grants had at least one 'foreign component' – mostly in the UK, Canada, Germany and Australia – on projects ranging from cancer to Aids, Ebola to child health.
'These decisions will have tragic consequences,' Prof Francis Collins, who led the NIH for 12 years, told Nature.
He added that when combined with the dismantling of USAID – which also funded research into diseases including malaria and tuberculosis – it means 'more children and adults in low-income countries will now lose their lives because of research that didn't get done'.
The Telegraph has contacted Mr Holbrook and the NIH press office.
Protect yourself and your family by learning more about Global Health Security
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Washington Post
17 minutes ago
- Washington Post
Maine clinics hope to get blocked Medicaid funds restored as they sue Trump administration over cuts
PORTLAND, Maine — A network of clinics that provides health care in Maine is expected to ask a judge Thursday to restore its Medicaid funding while it fights a Trump administration effort to keep federal money from going to abortion providers. President Donald Trump's policy and tax bill, known as the ' big beautiful bill ,' blocked Medicaid money from flowing to Planned Parenthood, the nation's largest abortion provider. The parameters in the bill also stopped funding from reaching Maine Family Planning, a much smaller provider that provides health care services in one of the poorest and most rural states in the Northeast.

Associated Press
17 minutes ago
- Associated Press
Maine clinics hope to get blocked Medicaid funds restored as they sue Trump administration over cuts
PORTLAND, Maine (AP) — A network of clinics that provides health care in Maine is expected to ask a judge Thursday to restore its Medicaid funding while it fights a Trump administration effort to keep federal money from going to abortion providers. President Donald Trump's policy and tax bill, known as the ' big beautiful bill,' blocked Medicaid money from flowing to Planned Parenthood, the nation's largest abortion provider. The parameters in the bill also stopped funding from reaching Maine Family Planning, a much smaller provider that provides health care services in one of the poorest and most rural states in the Northeast. Maine Family Planning filed a federal lawsuit last month seeking to restore reimbursements. Lawyers and representatives for Maine Family Planning say its 18 clinics provide vital services across the state including cervical cancer screenings, contraception and primary care to low-income residents. They also say the funding cut occurred even though Medicaid dollars are not used for its abortion services. 'Without Medicaid, MFP will be forced to stop providing all primary care for all patients — regardless of their insurance status — by the end of October,' the organization said in a statement, adding that about 8,000 patients receive family planning and primary care from the network. It also said many Maine Family Planning clinics 'provide care in very rural areas of the state where there are no other health care providers, and around 70% of their patients rely exclusively on MFP and will not see any other health care provider in a given year.' In court documents, Anne Marie Costello, deputy director for the Center for Medicaid & CHIP Services, called the request to restore funding 'legally groundless' and said it 'must be firmly rejected.' 'The core of its claim asks this Court to revive an invented constitutional right to abortion — jurisprudence that the Supreme Court decisively interred — and to do so in a dispute over federal funds,' Costello said. While advocates of cutting Medicaid for abortion providers focused on Planned Parenthood, the bill did not mention it by name. Instead it cut off reimbursements for organizations that are primarily engaged in family planning services — which generally include things such as contraception, abortion and pregnancy tests — and received more than $800,000 from Medicaid in 2023. The U.S. Senate's parliamentarian rejected a 2017 effort to defund Planned Parenthood because it was written to exclude all other providers by barring payments only to groups that received more than $350 million a year in Medicaid funds. Maine Family Planning asserts in its legal challenge that the threshold was lowered to $800,000 this time around to make sure Planned Parenthood would not be the only entity affected. It is the only other organization that has come forward publicly to say its funding is at risk.


Time Business News
an hour ago
- Time Business News
Hygiene Tech Meets Healing Proteins
Hospital-acquired infections can be caused by the cross-infection from surface and skin of patient, equipment, and healthcare staff. Various types of products and services are available to control hospital-acquired infections such as sterilization, cleaning & disinfection products, protective barriers, and endoscope reprocessing products. Increase in awareness regarding personal hygiene after COVID-19 is a major factor to boost the Hospital Infection Prevention and Control growth. Growth factors, proteins or peptides found in nature, are important for the control of cell actions like growth, specialization, movement, and survival. They attach to certain receptors on cell surfaces, which starts signals inside the cells that change how they act. Growth factors are needed for body functions such as development in embryos, healing wounds, fixing tissues, and immune reactions. Key Growth Drivers and Opportunities High Cases of Hospital Acquired Infections: Hospital-acquired infections (HAIs) remain a major risk to patient safety and healthcare results around the world. These infections, often caused by bacteria like Staphylococcus aureus, Clostridium difficile, and Escherichia coli, usually happen because of long hospital stays, surgeries, poor infection control, and antibiotic resistance. Those in intensive care, people with weak immune systems, and those having surgery are at risk. HAIs raise sickness and death rates; these also cause higher medical costs and longer stays in hospitals. Growing Geriatric Population: The growing geriatric population significantly contributes to the rise in hospital-acquired infections, as older adults often have weakened immune systems and require frequent medical care or hospitalization. This increases their vulnerability to infections, driving the demand for effective hospital infection prevention and control measures. As a result, healthcare facilities are investing more in disinfection, protective equipment, and sterilization solutions to ensure patient safety and reduce infection risks in aging populations. Challenges Failure of end-users to follow infection prevention rules limits how well hospital infection control works. When staff, patients, or support people don't follow hygiene rules—such as washing hands, sterilizing tools, or using safety gear— the risk of contamination and infections rises. Innovation and Expansion NAVTA & Virox Launch Free Infection Control Training for Safer Vet Care In March 2023, (National Association of Veterinary Technicians in America) NAVTA, Virox launch certificate program in infection prevention, to advance best practices in infection prevention. This program is a free online program designed to provide professionals with the knowledge needed to reduce the risk of spreading infection and create a safer workplace for their team, patients, and clients. NeoIPC Unveils Toolkit to Shield Newborns from Hospital Infections In November 2023, The NeoIPC Consortium announced the launch of a new surveillance toolkit to help neonatal intensive care units (NICUs) track and prevent hospital-acquired infections (HAIs) in high-risk newborns, including very preterm infants. This toolkit aims to standardize how infections are tracked in Newborn Intensive Care Units (NICUs) to allow for improved data gathering and assessment. It has tools, training, and reporting forms made for newborn care locations. By helping with early detection and response, this project hopes to lower infection rates and improve results for fragile newborns. Inventive Sparks, Expanding Markets The key players operating the hospital infection prevention and control market includes, 3M Company, Crosstex International, Inc., Johnson & Johnson, Belimed AG, among others. Worldwide business aims center on encouraging lasting growth, improving health and safety for the public, and boosting progress through cooperation. About Author: Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business. TIME BUSINESS NEWS